INTRODUCTION
Bone marrow suppression characterized by abnormal haematological indices is one of the serious adverse effects of antiretroviral drugs, especially the nucleoside reverse transcriptase inhibitors (Renner et al., 2013) . Anaemia, one of the commonest manifestations of bone marrow suppression, often resolves when treatment is initiated with antiretroviral drugs (Kerkhoff et al., 2014) . However, this anaemia could get worse if nucleoside reverse transcriptase inhibitors, especially zidovudine, are components of the antiretroviral regimen. In a study, Curkendall et al. found that HIV patients initiating zidovudine-containing antiretroviral regimen were at greater risk of developing anaemia or worsening of existing ones than patients initiating non-zidovudine-containing regimen Curkendal et al., 2007) .
This often results in discontinuation of treatment and worsening of the patient's condition (Nunez, 2006) . Discontinuation of antiretroviral treatment worsens drug resistance which is also very common with these agents. This invariably contributes to increased incidence of hospital admission. Prevention of ART-induced anaemia will, therefore, contribute positively to effective treatment of HIV/AIDS patients.
The most important treatment of drug-induced hematologic disorders is removal of the offending drug and supportive care of the patient (Rao, 2014) . Pharmacological methods of ameliorating drug-induced anaemia include the use of folic acid, corticosteroids, rituximab (a humanized monoclonal antibody), recombinant human erythropoietin (rHu Epo), and human granulocyte/monocyte colony stimulating factor (Matsumoto et al., 1990; Somogyi et al., 1996; Dietrickx et al., 2015) . However, some of these drugs appear ineffective and may even present their own problems. Besides, some of them are very costly especially when some are to be taken for a long time before the manifestation of their beneficial effects.
Ocimum gratissimum is a vegetable that is edible, so the chances of it being toxic are minimal. In fact, it has been demonstrated that its extract, when administered to albino rats for 28 days at a dose of 80 mg/kg did not result in any toxic effect to the liver (Ughachukwu et al., 2016) . This plant, also known as scent leaf (nchuanwuin Igbo) belongs to the family Lamiaceaae and is commonly used in the treatment of fever, diarrhoea, dysentery, pile, and convulsions (Prabhu et al., 2009) . Previous phytochemical studies on this plant revealed the presence of alkaloids, phytates, tannins, flavonoids, and oligosaccharides (Maria et al., 2004) .
Justification for the study
There is high incidence and prevalence of zidovudine-containing anti-retroviral induced anaemia. This anaemia, when moderate or severe, may warrant discontinuation of antiretroviral therapy with the attendant increase in hospital stay, increase in the cost of treatment, and increase in morbidity and mortality. The disruption of therapy also encourages the emergence of resistant strains of HIV which increases the prevalence of HIV/AIDS and the resultant public health concerns. Previous studies had shown that the aqueous leaf extract of Ocimum gratissimum when taken orally over a one month period increased the haemoglobin level in rats (Shehu et al., 2012; Ofem et al., 2012) . It was therefore suggested that the combination of this herb with antiretroviral drugs could reduce the incidence of anaemia associated with the nucleoside reverse transcriptase inhibitors especially zidovudine.
OBJECTIVES OF THE STUDY
The main objective of the study is to determine if the aqueous leaf extract of O.gratissimum has a protective effect on haematological indices in zidovudine-containing ART-treated rats. Specific objectives include: a. To determine the effect of abacavir, efavirenz, and zidovudine on haemoglobin level and PCV in rats. b. To determine the effect of aqueous leaf extract of O.gratissimum on haemoglobin level and PCV in rats. c. To determine the effect of aqueous leaf extract of O.gratissimum on haemoglobin level and PCV in zidovudine-containing ART-treated rats.
Hypotheses
The Null hypothesis states that aqueous leaf extract of O. gratissimum does not decrease haemoglobin level and PCV in zidovudine-containing ART-treated rats. The alternative hypothesis states that aqueous leaf extract of O. gratissimum decreases haemoglobin level and PCV in ART-treated rats. The null hypothesis would be tested at a significant level (p value) of 0.05. It would be rejected if the p value is < 0.05 and accepted if p value > 0.05. At p value < 0.05, the null hypothesis would be rejected implying that aqueous leaf extract of O. gratissimum decreases haemoglobin level and PCV in zidovudine-containing ART-treated rats.
MATERIALS AND METHODS
This study was conducted at the Pharmacology laboratory, Department of Pharmacology and Therapeutics, College of Medicine, ChukwuemekaOdumegwuOjukwu University,Awka Campus.
Calculation of sample size:
Sample size [N] of 25 rats at 95% power to detect a difference between means of 2.5 at a significant level (alpha) of 0.05 (two tailed) was chosen using the special formula for the calculation of sample size for laboratory animal experiments (NRC, 2003) :
Where, C = a constant [7.8] at 0.05 level of significance; s = 2.75 [standard deviation from a similar previous study] ( Youm et al., 2010) ; d = difference between means desired in present study.
Animal source:
Twenty five (25) rats of both sexes, 6-8 weeks old, were obtained from the animal house, Department of Pharmacology and Therapeutics, Chukwuemeka Odumegwu Ojukwu University, Awka Campus, Nigeria. The animals were certified healthy by a veterinarian. Each group of 5 rats was housed in a metal cage measuring 60cm x 45cm x 30cm and was allowed free access to animal feeds (Growers, Top Feeds, Nigeria) and clean drinking water. Left over feeds and water were discarded and the cages cleaned with chlorhexidine antiseptic solution every 12 hours. Artificial light was provided by fluorescent lamp (Philips, Holland; 18 watts) and light-dark cycle of 12-12 hours maintained. The animals were maintained in this arrangement for two weeks for acclimatization.
Preparation of plant extracts:
Two (2) kilogrammes of fresh leaves of O.gratissimumwas collected, washed under running tap water,and air-dried at room temperature. Thereafter, the dried leaves were ground into fine powder and 50 grammesof the powder were extracted with 500 ml of distilled water using the Soxhlet method (Pirie, 1975) . The filtrate was obtained by solvent evaporation.
Experimental procedure:
The rats were randomly divided into 5 groups of 5each. Thereafter, we treated the animals with the following drugs by gastric gavage for 28 days (Sule et al., 2012) as follows:
Group A: Each rat was given normal feed (no ART, no extract) Group B: Each rat was given efavirenz(Ranbaxy, India) 8.6 mg/kg, abacavir (Ranbaxy, India) 8.6 mg/kg, and zidovudine (Ranbaxy, India) 4.3 mg/kg (Kayode et al., 2011) . Group C: Each rat was given 80 mg/kg aqueous leaf extract of O. gratissimum. Group D: Each rat was given efavirenz 8.6 mg/kg, abacavir 8.6 mg/kg, and zidovudine 4.3 mg/kg, plus 40 mg/kg aqueous leaf extract of O. gratissimum (Uhegbu et al., 2012) . Group E: Each rat was given efavirenz 8.6 mg/kg, abacavir 8.6 mg/kg, and zidovudine 4.3 mg/kg, plus 80 mg/kg aqueous leaf extract of O. gratissimum. A treatment chart was maintained. After 28 days, blood samples were collected from each rat for the estimation of haemoglobin and PCV.
Collection of blood samples:
The rats were anaesthetized, one at a time, using intramuscular ketamine (Nirma, India) and diazepam (Norris Medicals, India) 50mg/kg and 5mg/kg respectively (RAR, 2009). Thereafter, blood samples were collected using the method described byHoff (2000) . Briefly, the skin over the jugular vein was cleaned with methylated spirit-soaked cotton wool and 1.0-1.5 mls of whole blood withdrawn through the jugular vein using a 25G hypodermic needle fitted unto a 2ml syringe. The withdrawn blood samples was transferred gently into heparinized specimen bottles, stored at 2-8 o C, and analyzed within 24 hours for haemoglobin concentration (Hb) and packed cell volume (PCV) using Haematology Autoanalyser (Erma Inc, PCE-210).
Statistical analysis:
The mean values (± S.E.M.) of HB and PCV were calculated. Then the data were tested for normality using D'Augostino and Pearson omnibus normality test. Thereafter, values of HB and PCV obtained for the test and control groups of rats were tested for statistically significant differences using Kruskal-Wallis test plus Dunn's multiple comparisons. There was no transformation of data. All the statistical tests were performed using Graph Pad Prism 7.0 and the results taken as statistically significant if the p value < 0.05.
RESULTS
The mean values (± S.E.M.) of the haemoglobin concentration (HB) were 12.7± 0.7, 13.7± 0.8, 11.6 ± 1.4, 12.2 ±1.7, and 13.9 ± 1.0 for groups A, B, C, D, and E respectively ( Table 1) . The mean values (± S.E.M.) of Packed Cell volume (PCV) are 38.2± 2.2, 41.4 ± 2.2, 35.0 ± 4.1, 36.8 ± 4.9, and 41.3 ± 3.0 for groups A, B, C, D, and E respectively ( Table 2) . Kruskal-Wallis test followed by Dunn's multiple comparison performed on the values of HB and PCV for the groups did not yield any statistically significant differences as shown in Figures 1, 2, 3 , and 4 (P values 0.7368 and 0.7325 for haemoglobin and PCV values respectively). 
DISCUSSION
The results show that neither antiretroviral drugs nor aqueous leaf extract of Ocimum gratissimum increased or reduced the haemoglobin level or the PCV in the rats during the course of the experiment. The findings agree with that of Ikeh who found that this extract did not protect against cyclophosphamide-induced bone marrow suppression in albino rats (Ikeh, 2013) . However, the findings contrast with those from some earlier studies. For instance, Ukoha et al. (2015) found that zidovudine at a dose of 0.8 mg/kg for 28 days significantly reduced the haemoglobin level and PCV in adult rats. Also other studies found that these two haematologic indices were significantly increased in adult rats that were fed with the extracts of O. gatissimum for 28 days (Shehu et al., 2012; Ofem et al., 2012) . These differences in results could be as a result of differences in the dosage of extracts used. For example, this study used a maximum dose of 80 mg/kg whereas these earlier authors used 1000 mg/kg. Also, the addition of the extract of O. gratissimum to the antiretroviral regimen may have affected the propensity of zidovudine to reduce the heamoglobin and PCV even though group C rats (extract alone) did not record higher haemoglobin and PCV values. Other factors could also be responsible for the differences in the results. For instance, the age of plant at harvest, soil characteristics, and other environmental variables affect the active constituents of medicinal plants (Evans, 2002) . Also, possible genetic differences between the groups of rat and those used in earlier studies could also be contributory. The ability of the rats to maintain normoglobinaemia during the cause of antiretroviral therapy despite the inclusion of zidovudine in the ART regimen was unexpected since zidovudine is credited with the highest tendency to cause anaemia (Agarwal et al., 2010) . The reason could be because the rats were not having HIV infection which usually has anaemia as one of its cardinal symptoms. Besides, it takes as long as six months for the effect of antiretroviral drugs on haemoglobin level to become evident (Daka et al., 2013) . Therefore, for any agent to increase or reduce haemoglobin level, that agent must necessarily be present for a long enough period of time to affect erythropoietin production. In this study, the rats were treated with the drugs for only 28 days.
Reduced erythropoietin production appears to be pivotal to the anaemia of HIV infection (Renner et al., 2013; Tadele, 2014) , but there is no direct evidence linking zidovudine-induced anaemia with reduced plasma erythropoietin levels. However, zidovudine causes megaloblastic anaemia by direct toxicity to the erythroid and myeloid cell lines in the bone marrow. This reversible toxicity is observed within 3-6 months of treatment (Anonymous, 2010) . Interestingly, zidovudine-induced anaemia responds very well to the administration of erythropoietin and recombinant granulocyte-macrophage colony stimulating factor (Rang et al., 2003) . This suggests
